Oscar Health forecasts $2.25 EPS without government help, stock trades at 0.3x sales with 500% upside if ACA survives!
Oscar Health is sitting in a strange pocket of the market. The stock trades at $14.93, down 28% from its April highs, and right on top of multi-year support. The valuation is compressed to 0.3x sales, with 42% revenue growth … Read more